Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vivek Chavda, Rajashri Bezbaruah, Tutumoni Kalita, Anupam Sarma, Juti Rani Devi, Ratnali Bania & Vasso Apostolopoulos. (2022) Variant influenza: connecting the missing dots. Expert Review of Anti-infective Therapy 20:12, pages 1567-1585.
Read now
Read now
Pedro Plans. (2008) Recommendations for the prevention and treatment of influenza using antiviral drugs based on cost–effectiveness. Expert Review of Pharmacoeconomics & Outcomes Research 8:6, pages 563-573.
Read now
Read now
Sigvard Olofsson & Tomas Bergström. (2005) Glycoconjugate glycans as viral receptors. Annals of Medicine 37:3, pages 154-172.
Read now
Read now
Frida Ganestam, Cecilia Stålsby Lundborg, Katarzyna Grabowska, Otto Cars & Annika Linde. (2003) Weekly Antibiotic Prescribing and Influenza Activity in Sweden: A Study throughout Five Influenza Seasons. Scandinavian Journal of Infectious Diseases 35:11-12, pages 836-842.
Read now
Read now
Articles from other publishers (17)
Christina Pfab, Luisa Schnobrich, Samir Eldnasoury, André Gessner & Nahed El-Najjar. (2021) Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?. Cancers 13:13, pages 3193.
Crossref
Crossref
Shai Mulinari & Courtney Davis. (2018) Regulatory scientists’ work has important ramifications for public health and should be open to public scrutiny. Health Research Policy and Systems 16:1.
Crossref
Crossref
Nikolaos P.E. Kadoglou, John Parissis, Petar Seferovic & Gerasimos Filippatos. (2018) La vacunación en la insuficiencia cardiaca: una estrategia que mejora el pronóstico. Revista Española de Cardiología 71:9, pages 697-699.
Crossref
Crossref
Nikolaos P.E. Kadoglou, John Parissis, Petar Seferovic & Gerasimos Filippatos. (2018) Vaccination in Heart Failure: An Approach to Improve Outcomes. Revista Española de Cardiología (English Edition) 71:9, pages 697-699.
Crossref
Crossref
Hannah Kraicer-Melamed, Margaret K Doll, Constantina Boikos, Nicholas Winters, Leora Frimer, Robert Stirling, Genevieve Gore & Caroline Quach. (2018) A scoping review of existing guidelines and recommendations for the use of influenza antiviral medications. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2:2, pages 16-32.
Crossref
Crossref
Ching-Tai Huang, Chen-Yiu Hung, Tse-Ching Chen, Chun-Yen Lin, Yung-Chang Lin, Chia-Shiang Chang, Yueh-Chia He, Yu-Lin Huang & Avijit Dutta. (2017) Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model. Scientific Reports 7:1.
Crossref
Crossref
Paul Zarogoulidis, Theodoros Constantinidis, Paschalis Steiropoulos, Nikolaos Papanas, Kostas Zarogoulidis & Efstratios Maltezos. (2011) Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?. BMC Research Notes 4:1.
Crossref
Crossref
Tobias Svensson, Fredrik Granath, Olof Stephansson & Helle Kieler. (2011) Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy. Pharmacoepidemiology and Drug Safety 20:10, pages 1030-1034.
Crossref
Crossref
Daphne Ling & Dick Menzies. (2010) Occupation-Related Respiratory Infections Revisited. Infectious Disease Clinics of North America 24:3, pages 655-680.
Crossref
Crossref
Iain Stephenson, Tristan W. Clark & Manish Pareek. (2008) Antiviral treatment and prevention of seasonal influenza: A comparative review of recommendations in the European Union. Journal of Clinical Virology 42:3, pages 244-248.
Crossref
Crossref
Anthony Luke & Pierre d'Hemecourt. (2007) Prevention of Infectious Diseases in Athletes. Clinics in Sports Medicine 26:3, pages 321-344.
Crossref
Crossref
Bo-Eric Malmvall, Ingeborg Franzen, Per-Erik Åbom & Maj-Britt Hugosson. (2007) The Rate of Influenza Immunization to People Aged 65 Years and Older Was Increased From 45% to 70% by a Primary Health Care–based Multiprofessional Approach. Quality Management in Health Care 16:1, pages 51-59.
Crossref
Crossref
Ronan Le Goffic, Viviane Balloy, Micheline Lagranderie, Lena Alexopoulou, Nicolas Escriou, Richard Flavell, Michel Chignard & Mustapha Si-Tahar. (2006) Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia. PLoS Pathogens 2:6, pages e53.
Crossref
Crossref
Fotini B Karassa & John P A Ioannidis. 2005. Evidence‐based Respiratory Medicine. Evidence‐based Respiratory Medicine
335
347
.
Arvydas Ambrozaitis, Stefan Gravenstein, Gerrit A. van Essen, Ethan Rubinstein, Ligita Balciuniene, Ausra Stikleryte, Catriona Crawford, Michael Elliott & Peter Shult. (2005) Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population. Journal of the American Medical Directors Association 6:6, pages 367-374.
Crossref
Crossref
P. Wutzler, K.-D. Kossow, H. Lode, B.R. Ruf, H. Scholz & G.E. Vogel. (2004) Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Journal of Clinical Virology 31:2, pages 84-91.
Crossref
Crossref
S Mashiba, T Takahashi, N Hayashi, H Morita, T Gotoh, M Nakata, Y Watoh, T Kanda & M Takino. (2004) Features of Patients with Influenza Virus Infection Examined in the Emergency Department of a University Hospital in North-western Japan. Journal of International Medical Research 32:3, pages 331-336.
Crossref
Crossref